Mary Ellen Gilder|Thet Wai Zin|Nan San Wai|Ma Ner|Paw Si Say|M Htoo|Say Say|Win Win Htay|Julie A Simpson|Sasithon Pukrittayakamee|François Nosten|Rose McGready
Gestational diabetes mellitus prevalence in Maela refugee camp on the Thai–Myanmar Border: a clinical report
Mahidol Oxford Tropical Medicine Research Unit|Shoklo Malaria Research Unit|Mahidol University|Mahidol Oxford Tropical Medicine Research Unit|Shoklo Malaria Research Unit|Mahidol University|Mahidol Oxford Tropical Medicine Research Unit|Shoklo Malaria Research Unit|Mahidol University|Mahidol Oxford Tropical Medicine Research Unit|Shoklo Malaria Research Unit|Mahidol University|Mahidol Oxford Tropical Medicine Research Unit|Shoklo Malaria Research Unit|Mahidol University|Mahidol Oxford Tropical Medicine Research Unit|Shoklo Malaria Research Unit|Mahidol University|Mahidol Oxford Tropical Medicine Research Unit|Shoklo Malaria Research Unit|Mahidol University|Mahidol Oxford Tropical Medicine Research Unit|Shoklo Malaria Research Unit|Mahidol University|University of Melbourne|Mahidol Oxford Tropical Medicine Research Unit|Mahidol University|Mahidol Oxford Tropical Medicine Research Unit|Shoklo Malaria Research Unit|Mahidol University|University of Oxford|Mahidol Oxford Tropical Medicine Research Unit|Shoklo Malaria Research Unit|Mahidol University|University of Oxford
individuals conflictaffected areas rarely get appropriate care chronic noninfectious diseases prevalence gestational diabetes mellitus gdm increasing worldwide new evidence shows conclusively negative effects hyperglycemia occur even mild glucose elevations negative effects attenuated treatment scientific literature gestational diabetes refugee camp settings critically limiteda 75 g 2hour glucose tolerance test administered 228 women attending antenatal care anc clinic maela refugee camp thaimyanmar border prevalence gdm determined using hapo trial cutoffs 92 mgdl fasting180 1 hour and153 2 hour criteria 126 mgdl fasting 140 mgdl 2 hourfrom july 2011 march 2012 prevalence gdm 101 95 confidence interval ci 62140 cutoff determined hapo trial applied applying older criteria yielded prevalence 66 95 ci 3398 age parity bmi emerged characteristics may significantly associated gdm population risk factors commonly used screening guidelines applicable diabetesnave populationthe prevalence gdm lower population compared populations still complicates 10 pregnancies new evidence regarding gestational diabetes raises new dilemmas healthcare providers resourcepoor settings efforts identify treat patients risk adverse outcomes need balanced awareness risks burdens associated diagnosis unnecessary interventions screening approaches based risk factors using higher cutoff values may help minimize burden identify likely benefit intervention